33.95
Sanara Medtech Inc stock is traded at $33.95, with a volume of 93,685.
It is up +11.24% in the last 24 hours and up +28.70% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$30.52
Open:
$31.02
24h Volume:
93,685
Relative Volume:
2.14
Market Cap:
$302.23M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-65.29
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
+14.39%
1M Performance:
+28.70%
6M Performance:
+0.77%
1Y Performance:
+2.97%
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SMTI
Sanara Medtech Inc
|
33.95 | 281.14M | 64.99M | -4.30M | -3.51M | -0.52 |
![]()
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
Dec-23-24 | Initiated | H.C. Wainwright | Buy |
May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Why Sanara MedTech Inc. is moving today2025 Geopolitical Influence & High Accuracy Investment Signals - Newser
Should you hold or exit Sanara MedTech Inc. nowRecession Risk & Trade Opportunity Analysis - Newser
How to read the order book for Sanara MedTech Inc.2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
Sanara MedTech (NASDAQ:SMTI) Releases Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
Is now a turning point for Sanara MedTech Inc.Quarterly Trade Summary & Intraday High Probability Alerts - Newser
How to interpret RSI for Sanara MedTech Inc. stock2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Will Sanara MedTech Inc. rebound enough to break evenEarnings Risk Report & AI Enhanced Trading Alerts - Newser
Will Sanara MedTech Inc. Stock Benefit from AI and Green Energy Trends2025 Trade Ideas & Weekly Setup with ROI Potential - Newser
Statistical indicators supporting Sanara MedTech Inc.’s strength2025 Top Decliners & Community Verified Trade Alerts - Newser
Visual trend scoring systems applied to Sanara MedTech Inc.Market Growth Summary & Risk Managed Trade Strategies - Newser
What to expect from Sanara MedTech Inc. in the next 30 daysQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
What to do if you’re stuck in Sanara MedTech Inc.July 2025 Drop Watch & High Return Trade Opportunity Guides - Newser
How to monitor Sanara MedTech Inc. with trend dashboardsWeekly Risk Report & Growth-Oriented Investment Plans - Newser
FY2025 EPS Estimate for Sanara MedTech Raised by Analyst - MarketBeat
Automated trading signals detected on Sanara MedTech Inc.2025 Price Targets & Free Verified High Yield Trade Plans - Newser
What MACD signals say about Sanara MedTech Inc.Quarterly Profit Review & Technical Pattern Based Signals - Newser
Is Sanara MedTech Inc. likely to announce a buybackMarket Performance Recap & Capital Protection Trading Alerts - sundaytimes.kr
Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates - MSN
H.C. Wainwright raises Sanara MedTech stock price target to $54 on strong Q2 - Investing.com
What does recent volatility data suggest for Sanara MedTech Inc.Portfolio Value Summary & Weekly Setup with High ROI Potential - Newser
Advanced analytics toolkit walkthrough for Sanara MedTech Inc.Weekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
How to forecast Sanara MedTech Inc. trends using time seriesEarnings Recap Summary & Daily Stock Trend Watchlist - Newser
Published on: 2025-08-17 02:18:31 - Newser
Multi asset correlation models including Sanara MedTech Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
How Sanara MedTech Inc. stock performs during market volatilityTrend Reversal & Fast Gain Swing Trade Alerts - thegnnews.com
The Sanara MedTech Inc. (NASDAQ:SMTI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
Long term hold vs stop loss in Sanara MedTech Inc.Wall Street Watch & Risk Managed Investment Signals - Newser
Tools to assess Sanara MedTech Inc.’s risk profile2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Sanara MedTech outlines $5.5M–$6.5M THP investment target while advancing surgical segment growth - MSN
Can trapped investors hope for a rebound in Sanara MedTech Inc.July 2025 Big Picture & Weekly Market Pulse Updates - Newser
Has Sanara MedTech Inc. found a price floor2025 Trading Recap & Daily Growth Stock Investment Tips - Newser
How volatile is Sanara MedTech Inc. stock2025 Pullback Review & Free Fast Gain Swing Trade Alerts - thegnnews.com
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):